Mobilized Leukopaks with High CD34+ Yield and Low Granulocyte Content
Understand how Discovery Life Sciences’ AllCells division delivers mobilized leukopaks with high CD34+ yield, low granulocyte content, and a reliable 98% collection deliverability rate within just three weeks.